The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Molecular and Cellular Pharmacology
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Molecular and Cellular Pharmacology.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Molecular and Cellular Pharmacology.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Molecular and Cellular Pharmacology are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
19. International Conference on Molecular and Cellular Pharmacology has teamed up with the Special Journal Issue on
Molecular and Cellular Pharmacology.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Molecular pharmacology
Advances in molecular pharmacology
Molecular and cellular pharmacology
Molecular and cellular basis of drug actions
Effects of pharmacological agents on gene regulation, chromosome structure, protein function and modification
Pharmacogenomics and pharmacoproteomics
Clinical pharmacology including pharmacokinetics, pharmacodynamics, pathways of drug metabolism, and drug-drug interactions
Immunopharmacology including immunotherapy, immunotoxicology, and immunopathology
Toxicology including toxicokinetics and toxicodynamics
Radiopharmacology including radiopharmaceuticals, development and characterization of novel imaging agents, and radiation and drug interactions
| Abstracts/Full-Text Paper Submission Deadline |
|
November 28, 2024 |
| Notification of Acceptance/Rejection |
|
December 12, 2024 |
| Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
February 11, 2025 |
| Conference Dates |
|
March 10-11, 2025 |
